Beyond the White Pill: Advocating for Racial Diversity in IBD Trials

Beyond the White Pill: Advocating for Racial Diversity in IBD Trials

Abstract Although inflammatory bowel disease [IBD] affects an increasingly diverse patient population, most patients in IBD clinical trials are White. Acknowledging current barriers and taking meaningful action is required at multiple levels to improve racial diversity across clinical trials in IBD....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of Crohn's and colitis 2023-04, Vol.17 (3), p.459-461
Hauptverfasser: Wong, Emily C L, Moayyedi, Paul, Narula, Neeraj
Format: Artikel
Sprache:eng
Schlagworte:
Humans
Inflammatory Bowel Diseases - drug therapy
Racial Groups
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Although inflammatory bowel disease [IBD] affects an increasingly diverse patient population, most patients in IBD clinical trials are White. Acknowledging current barriers and taking meaningful action is required at multiple levels to improve racial diversity across clinical trials in IBD. Ultimately, improving racial diversity in trials can in turn improve the care received by the diverse patients seen in clinical practice.
ISSN:1873-9946
1876-4479
DOI:10.1093/ecco-jcc/jjac134